SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BIOMIRA RESEARCH (BIOM)
An SI Board Since November 1999
Posts SubjectMarks Bans Symbol
72 7 0 BRA
Emcee:  chirodoc Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
47 Biomira Announces Expansion of Equity Line... for Up to U.S.100 Million Finachirodoc-2/3/2000
46 GREAT VALUATION POST--READ IT! Below I have reposted a valuation written by mikchirodoc-1/30/2000
45 One of the primary advantages of BIOM's liposomal formulation is the abilitchirodoc-1/30/2000
44 Merrill Lynch Bulletin Biomira Inc........1/25/00 Andre Uddin, Ph D., Senior Anchirodoc-1/29/2000
43 Biomira - Encouraging Phase I BLP25 Vaccine Survival Data in Non-Small Cell Lunchirodoc-1/26/2000
42 *OT*<"Teleric"> Probably a typo, TLRK, Tularik. ___ An articleMike McFarland-1/22/2000
41 In a new report yesterday, Merrill Lynch Canada Inc. analyst Andre Uddin raisedchirodoc-1/22/2000
40 Paul Able, Manager of The Medical Fund The following interview was conducted bychirodoc-1/22/2000
39 NEW VISTAS IN CANCER TREATMENT Modern vaccines specifically designed to treat chirodoc-1/20/2000
38 News that will drive stock by: moleculemike 1/19/00 5:34 pm Msg: 13158 of 132chirodoc-1/19/2000
37 Thanks for keeping this board informative and interesting. Marvinmarvin friedman-1/15/2000
36 PII VS. PIII PATIENTS THE GREAT NUMBERS FROM THE PII BRIDGING STUDY WAS DONE Wchirodoc-1/15/2000
35 i expect full enrollment this summer and the first look at data Q1-Q2 2001. thchirodoc-1/13/2000
34 next year at this time, biom could be invited to HQ curtischirodoc-1/13/2000
33 Biomira Maintained Near-Term `Buy' at Merrill Toronto, Jan. 7 (Bloombergchirodoc-1/10/2000
32 Yesterday morning Andre Uddin put out an update of his recommendation of Biomirchirodoc-1/7/2000
31 i agree and think that by Q3 we should see some big moves--but this is the timechirodoc-1/2/2000
30 Chiro: Thanks for maintaining a consistent high level of commentary with regarJohn Curtis-1/2/2000
29 institutions in biom We already have significant interest from some funds. Frchirodoc-1/1/2000
28 PGNX vs. BIOM First I think comparisons such as this are not terribly meaningfchirodoc-12/28/1999
27 Biomira's BLP25 Liposome Technology Shows Strong Promise In Dendritic Celchirodoc-12/21/1999
26 Today's news further confirms the progress of BLP25 into the second half ofchirodoc-12/20/1999
25 December 1999 issue of Internal Medicine World (thanks j) on page 20, there ischirodoc-12/20/1999
24 Biomira Completes Enrollment in Phase II Lung Cancer Trial; Follow-On Trial On chirodoc-12/20/1999
23 Merrill-Lynch estimates The problem I have with Merrill's projection is tchirodoc-12/19/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News